Suppr
超能文献

Safety and Efficacy of Anti-TNF Therapy in Older Adults With Ulcerative Colitis: A New Path Forward.

作者信息

Faye Adam S, Dodson John A, Shaukat Aasma

机构信息

Department of Medicine, New York University School of Medicine, New York, New York.

出版信息

Gastroenterology. 2022 May;162(6):1762-1764. doi: 10.1053/j.gastro.2021.12.003. Epub 2021 Dec 2.

DOI:10.1053/j.gastro.2021.12.003

PMID:34864071

Abstract

摘要

相似文献

Safety and Efficacy of Anti-TNF Therapy in Older Adults With Ulcerative Colitis: A New Path Forward.

Gastroenterology. 2022 May;162(6):1762-1764. doi: 10.1053/j.gastro.2021.12.003. Epub 2021 Dec 2.

The efficacy of tumour necrosis factor-α antagonists in maintenance therapy for ulcerative colitis.

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1088. doi: 10.1097/MEG.0000000000002188.

Bloody Diarrhea and Weight Loss in a Patient in Remission From Ulcerative Colitis.

Gastroenterology. 2019 Nov;157(5):1207-1209. doi: 10.1053/j.gastro.2019.01.272. Epub 2019 Mar 1.

Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice.

Indian J Gastroenterol. 2020 Dec;39(6):565-575. doi: 10.1007/s12664-020-01092-1. Epub 2020 Oct 27.

Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.

Lancet Gastroenterol Hepatol. 2021 Jun;6(6):429-437. doi: 10.1016/S2468-1253(21)00062-5. Epub 2021 Apr 20.

SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.

Medicine (Baltimore). 2022 Jan 28;101(4):e28722. doi: 10.1097/MD.0000000000028722.

[Golimumab Therapy in Ulcerative Colitis].

Korean J Gastroenterol. 2016 Feb;67(2):64-73. doi: 10.4166/kjg.2016.67.2.64.

Golimumab: clinical update on its use for ulcerative colitis.

Drugs Today (Barc). 2015 Mar;51(3):171-84. doi: 10.1358/dot.2015.51.3.2298240.

Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?

Gut Liver. 2022 Jan 15;16(1):138-140. doi: 10.5009/gnl210246.

Golimumab for the treatment of ulcerative colitis.

Expert Opin Biol Ther. 2017 Jul;17(7):879-886. doi: 10.1080/14712598.2017.1327576. Epub 2017 May 16.

引用本文的文献

Management Considerations for the Older Adult With Inflammatory Bowel Disease.

Gastroenterol Hepatol (N Y). 2023 Oct;19(10):592-599.

Thiol-Disulfide Exchange Coordinates the Release of Nitric Oxide and Dexamethasone for Synergistic Regulation of Intestinal Microenvironment in Colitis.

Research (Wash D C). 2023 Aug 1;6:0204. doi: 10.34133/research.0204. eCollection 2023.

Managing the older adult with inflammatory bowel disease: is age just a number?

Curr Opin Gastroenterol. 2023 Jul 1;39(4):268-273. doi: 10.1097/MOG.0000000000000943. Epub 2023 May 23.

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Curr Treat Options Gastroenterol. 2022 Dec;20(4):564-581. doi: 10.1007/s11938-022-00405-x. Epub 2022 Dec 6.

Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes.

Aliment Pharmacol Ther. 2022 Jun;55(11):1459-1460. doi: 10.1111/apt.16936.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Safety and Efficacy of Anti-TNF Therapy in Older Adults With Ulcerative Colitis: A New Path Forward.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译